Aquaculture Vaccine Trends and Forecast
The future of the global aquaculture vaccine market looks promising with opportunities in the inactivated and dna markets. The global aquaculture vaccine market is expected to reach an estimated $0.7 billion by 2030 with a CAGR of 7.6% from 2024 to 2030. The major drivers for this market are increasing demand for food products derived from aquatic animals, notable rise in infectious diseases within the aquaculture sector, and expansion of aquaculture production.
A more than 150-page report is developed to help in your business decisions.
Aquaculture Vaccine by Segment
The study includes a forecast for the global aquaculture vaccine by product, route of administration, and region.
Aquaculture Vaccine Market by Product [Shipment Analysis by Value from 2018 to 2030]:
- Inactivated Vaccines
- DNA Vaccines
Aquaculture Vaccine Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:
Aquaculture Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Aquaculture Vaccine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies aquaculture vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the aquaculture vaccine companies profiled in this report include-
- GlaxoSmithKline
- Merck
- Pfizer
- Sanofi
- CSL
- Emergent BioSolutions
- Johnson & Johnson
- AstraZeneca
- Serum Institute of India
- Bavarian Nordic
Aquaculture Vaccine Market Insights
Lucintel forecasts that injected will remain the larger segment due to its widespread use in aquatic animals as a preventative measure against a number of illnesses, including as furunculosis, vibriosis, cold-water vibriosis, winter sore, IPN, and infectious salmon anemia (ISA).
APAC is expected to witness highest growth over the forecast period due to the presence of one of the region's largest aquaculture industries in the region.
Features of the Global Aquaculture Vaccine Market
Market Size Estimates: Aquaculture vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Aquaculture vaccine market size by product, route of administration, and region in terms of value ($B).
Regional Analysis: Aquaculture vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different products, route of administrations, and regions for the aquaculture vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the aquaculture vaccine market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q.1 What is the aquaculture vaccine market size?
Answer: The global aquaculture vaccine market is expected to reach an estimated $0.7 billion by 2030.
Q.2 What is the growth forecast for aquaculture vaccine market?
Answer: The global aquaculture vaccine market is expected to grow with a CAGR of 7.6% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the aquaculture vaccine market?
Answer: The major drivers for this market are increasing demand for food products derived from aquatic animals, notable rise in infectious diseases within the aquaculture sector, and expansion of aquaculture production.
Q4. What are the major segments for aquaculture vaccine market?
Answer: The future of the aquaculture vaccine market looks promising with opportunities in the inactivated and dna markets.
Q5. Who are the key aquaculture vaccine market companies?
Answer: Some of the key aquaculture vaccine companies are as follows:
- GlaxoSmithKline
- Merck
- Pfizer
- Sanofi
- CSL
- Emergent BioSolutions
- Johnson & Johnson
- AstraZeneca
- Serum Institute of India
- Bavarian Nordic
Q6. Which aquaculture vaccine market segment will be the largest in future?
Answer: Lucintel forecasts that injected will remain the larger segment due to its widespread use in aquatic animals as a preventative measure against a number of illnesses, including as furunculosis, vibriosis, cold-water vibriosis, winter sore, IPN, and infectious salmon anemia (ISA).
Q7. In aquaculture vaccine market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness highest growth over the forecast period due to the presence of one of the region's largest aquaculture industries in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
- Q.1. What are some of the most promising, high-growth opportunities for the aquaculture vaccine market by product (inactivated vaccines and DNA vaccines), route of administration (injected and oral), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
- Q.2. Which segments will grow at a faster pace and why?
- Q.3. Which region will grow at a faster pace and why?
- Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
- Q.5. What are the business risks and competitive threats in this market?
- Q.6. What are the emerging trends in this market and the reasons behind them?
- Q.7. What are some of the changing demands of customers in the market?
- Q.8. What are the new developments in the market? Which companies are leading these developments?
- Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
- Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
- Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
